Jeff Lazarus, Chair of Healthy Livers, Healthy Lives, joins the Surfers to discuss this global SLD Public Health coalition. and the role of “top-down” solutions.
In this conversation, updated MASLD CPG co-authors Frank Tacke and Elisabetta Bugianesi discuss some of the guidelines’ key goals and issues surrounding the screening, diagnosis and management of MASLD patients.
Co-authors Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the new MASLD Clinical Practice Guidelines from EASL, EASDand EASO.
Roger Green conducts 1:1 interviews with Mike Betel, Louise Campbell and Sven Francque while they are at the EASL Congress 2024, discussing key issues related to MASLD
Two abstracts for the EASL Congress 2024 from Hannes Hagstrom’s team leads the group to focus on the future of Big Data within MASLD diagnosis and therapies.
EASL Secretary General Aleksander Krag and our other guests, Hannes Hagstrom and Michelle Long, join Jörn Schattenberg and Roger Green to discuss MASLD-related highlights of EASL Congress 2024.
Panelists reflecting on Stephen Harrison share what they consider his most important and lasting professional accomplishments.
Michael Charlton and the Surfers discuss two issues: defining therapeutic futility for Rezdiffra and describing some advances in MASLD translational medicine
Michael Charlton describes the impact of Rezdiffra on practices and procedures in his clinic
Michael Charlton joins the Surfers for a far-reaching conversation, with topics ranging from how his clinic is integrating Rezdiffra in MASH patient treatment to exciting research, both reported and in development.
